These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

242 related items for PubMed ID: 18560214

  • 1. Importance of leukoaraiosis on CT for tissue plasminogen activator decision making: evaluation of the NINDS rt-PA Stroke Study.
    Demchuk AM, Khan F, Hill MD, Barber PA, Silver B, Patel S, Levine SR, NINDS rt-PA Stroke Study Group.
    Cerebrovasc Dis; 2008; 26(2):120-5. PubMed ID: 18560214
    [Abstract] [Full Text] [Related]

  • 2. A matched comparison of eptifibatide plus rt-PA versus rt-PA alone in acute ischemic stroke.
    Adeoye O, Knight WA, Khoury J, Schmit PA, Sucharew H, Broderick JP, Pancioli AM, CLEAR-ER Investigators.
    J Stroke Cerebrovasc Dis; 2014; 23(5):e313-5. PubMed ID: 24534128
    [Abstract] [Full Text] [Related]

  • 3. Computed Tomography--Verified Leukoaraiosis Is a Risk Factor for Post-thrombolytic Hemorrhage.
    Willer L, Havsteen I, Ovesen C, Christensen AF, Christensen H.
    J Stroke Cerebrovasc Dis; 2015 Jun; 24(6):1126-30. PubMed ID: 25920756
    [Abstract] [Full Text] [Related]

  • 4. Time of day, outcome, and response to thrombolytic therapy: the National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Trial experience.
    Rhoney DH, Coplin WM, Lin Y, Frankel M, Lyden PD, Levine SR.
    J Stroke Cerebrovasc Dis; 2010 Jan; 19(1):40-8. PubMed ID: 20123226
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Leukoaraiosis, Cerebral Hemorrhage, and Outcome After Intravenous Thrombolysis for Acute Ischemic Stroke: A Meta-Analysis (v1).
    Charidimou A, Pasi M, Fiorelli M, Shams S, von Kummer R, Pantoni L, Rost N.
    Stroke; 2016 Sep; 47(9):2364-72. PubMed ID: 27491738
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Eligibility determination for intravenous thrombolysis based on radiology interpretation report of the head CT scan in patients with acute ischemic stroke.
    Hassan AE, Majidi S, Janjua NA, Chaudhry SA, Tekle WG, Grigoryan M, Qureshi AI.
    J Neuroimaging; 2014 Sep; 24(4):349-53. PubMed ID: 24015702
    [Abstract] [Full Text] [Related]

  • 15. Modified diffusion-weighted imaging-Alberta Stroke Program Early Computed Tomography Score including deep white matter lesions predicts symptomatic intracerebral hemorrhage following intravenous thrombolysis.
    Tanaka K, Matsumoto S, Furuta K, Yamada T, Nagano S, Takase KI, Hatano T, Yamasaki R, Kira JI.
    J Thromb Thrombolysis; 2020 Jul; 50(1):174-180. PubMed ID: 31745858
    [Abstract] [Full Text] [Related]

  • 16. Pretreatment Blood Pressure is a Simple Predictor of Hemorrhagic Infarction after Intravenous Recombinant Tissue Plasminogen Activator (rt-PA) Therapy.
    Ohtani R, Nakamura M, Nirengi S, Kawakami O, Togawa J, Doi K, Sainouchi M, Kuwata Y, Takata M, Masuda Y, Matsunari R, Takeda K, Tsukahara T, Sakane N.
    J Stroke Cerebrovasc Dis; 2019 Jul; 28(7):1979-1986. PubMed ID: 30982718
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.